908 Devices Inc. Stock News

908 Devices Inc''s (NASDAQ: MASS ) Q4 FY21 revenue increased 177% Y/Y to $15.8 million , beating the consensus of $15.11 million. The increase was primarily driven by handheld revenue that increased 262%, mainly related to shipments to the US Army under the multi-year purchase order. Desktop revenue grew 53% Y/Y because of … Full story available on Benzinga.com

Futures Rebound On "Massive" EU Bond Stimulus Plan; Nickel Halted After Record Surge, Gold Over $2000 Futures rebounded from yesterday huge loss, and after touching a session low of 4,138, S&P futures bounced shortly after the European when Bloomberg reported that the European Union was set to reveal a quasi "Marshall Plan" this week to issue issue "potentially massive” joint bonds to fund energy and defense and help counter the fiscal fallout from Russia’s invasion of Ukraine (how Europe will do that at a time when QE is ending and buyers for global debt are shrinking fast amid surging rates remains unclear). S&P 500 futures gained 0.7% following the benchmark index’s biggest loss since October 2020, while Dow futures rose 0.6%. Contracts on the Nasdaq 100 were up 0.6% at 7:15 a.m. Bonds and the dollar dropped, and the euro strengthened. The commodity melt up continued: nickel was halted on the LME after soaring 250%, oil traded just shy of $130 and gold was above $2000. The EU''s bond-sale proposal may be presented as soon as next week, according to Bloomberg.

MASS earnings call for the period ending December 31, 2021.

908 Devices Inc.'s (MASS) CEO Kevin Knopp on Q4 2021 Results - Earnings Call Transcript

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 33.33% and 4.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here are four companies expected to report quarterly results either Monday afternoon or Tuesday morning.

The number of companies posting quarterly results drops below 500 next week, as the current earnings-reporting season winds down.

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, March 7, 2022. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of

908 Devices Inc (MASS) shares closed today at 1.4% above its 52 week low of $19.73, giving the company a market cap of $558M. The stock is currently down 22.7% year-to-date, down 63.5% over the past 12 months, and down 59.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 61.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 12.5% lower than its 5-day moving average, 18.9% lower than its 20-day moving average, and 34.6% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 206.6% The company's stock price performance over the past 12 months lags the peer average by 471.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

908 Devices Inc (MASS) shares closed this week 22.7% lower than it did at the end of last week. The stock is currently down 22.7% year-to-date, down 63.5% over the past 12 months, and down 59.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $26.63 and as low as $19.73 this week.Shares closed 74.9% below its 52-week high and 1.4% above its 52-week low.Trading volume this week was 73.1% higher than the 10-day average and 61.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 12.5% lower than its 5-day moving average, 18.9% lower than its 20-day moving average, and 34.6% lower than its 90-day moving average. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 206.6% The company's stock price performance over the past 12 months lags the peer average by 471.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

(RTTNews) - 908 Devices (MASS) announced that GlaxoSmithKline (GSK) has purchased an additional REBEL cell culture media analyzer. GSK will now have a total of five REBEL analyzers being used by its biologics and vaccine process development teams. REBEL is the first miniature CE-MS-based analyzer that enables biopharma researchers to accelerate

Emerald Mutual Fund Advisers Trust purchased a new stake in shares of 908 Devices Inc. (NASDAQ:MASS) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 95,368 shares of the companys stock, valued at approximately $3,101,000. Other hedge funds and other institutional []

According to the new market research report "Mobile Mass Spectrometers Market by Application (Homeland Security, Military & Defence, Environmental monitoring, Emergency/rapid response & Disaster Management, Narcotics Detection, Chemical leak detection, Forensics), & Region - Global Forecasts to 2026", published by